Orthopedic imaging software developer Voyant Health has received U.S. Food and Drug Administration (FDA) clearance for its TraumaCad Mobile digital templating software for mobile devices.
TraumaCad Mobile enables orthopedic surgeons to perform digital templating from any Web browser or iPad, giving them additional flexibility in planning total hip replacement surgery, according to the company.
Features available on the app include automatic hip replacement planning, automatic calibration through support for the KingMark calibration marker, a large library of digital hip templates, and functions supporting collaboration and inventory management.
TraumaCad Mobile can be used as a standalone app or as part of an enterprise implementation integrated with an existing PACS network, with security and administrative features.
